Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 73 (2-3), 135-141
- https://doi.org/10.1016/0021-9150(88)90034-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Molecular weights of apoprotein B obtained from human low-density lipoprotein (apoprotein B-PI) and from rat very low density lipoprotein (apoprotein B-PIII)Biochemistry, 1985
- Effect of Lipid Lowering Diet on Low Density Lipoprotein Receptor Activity in Freshly Isolated Peripheral Blood Mononuclear CellsActa Medica Scandinavica, 1985
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)Atherosclerosis, 1982
- Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabeticsAtherosclerosis, 1982
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Eine neue Bestimmung der Neutralfette im Blutserum und GewebeKlinische Wochenschrift, 1966